CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 76% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English

Trade Standard BioTools Inc - LAB CFD

1.6750
2.33%
  • Summary
  • Historical Data
Trading сonditions
Spread 0.0200
Long position overnight fee

Long position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment -0.024846 %
Charges from full value of position ($-4.72)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.024846%
Short position overnight fee

Short position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment 0.002624 %
Charges from full value of position ($0.50)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
0.002624%
Overnight fee time 21:00 (UTC)
Min traded quantity 1
Currency USD
Margin 5.00%
Stock exchange United States of America
Commission on trade 0%

Key Stats
Prev. Close 1.715
Open 1.695
1-Year Change -21.66%
Day's Range 1.655 - 1.705
  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Oct 25, 2024 1.6750 -0.0400 -2.33% 1.7150 1.7150 1.6550
Oct 24, 2024 1.7150 -0.0800 -4.46% 1.7950 1.8250 1.7150
Oct 23, 2024 1.7750 -0.0300 -1.66% 1.8050 1.8350 1.7750
Oct 22, 2024 1.8250 -0.0300 -1.62% 1.8550 1.8850 1.8050
Oct 21, 2024 1.8750 0.0100 0.54% 1.8650 1.8950 1.8450
Oct 18, 2024 1.8850 0.1100 6.20% 1.7750 1.8950 1.7750
Oct 17, 2024 1.7950 -0.0700 -3.75% 1.8650 1.8750 1.7750
Oct 16, 2024 1.8750 0.0400 2.18% 1.8350 1.9050 1.8350
Oct 15, 2024 1.8750 0.0100 0.54% 1.8650 1.9050 1.8550
Oct 14, 2024 1.8750 0.0500 2.74% 1.8250 1.8850 1.7850
Oct 11, 2024 1.8850 0.1300 7.41% 1.7550 1.8850 1.7550
Oct 10, 2024 1.7650 0.0300 1.73% 1.7350 1.7650 1.6850
Oct 9, 2024 1.7650 -0.0200 -1.12% 1.7850 1.7850 1.7150
Oct 8, 2024 1.7950 -0.0100 -0.55% 1.8050 1.8550 1.7750
Oct 7, 2024 1.8150 -0.0100 -0.55% 1.8250 1.8550 1.8050
Oct 4, 2024 1.8450 0.0200 1.10% 1.8250 1.8650 1.8050
Oct 3, 2024 1.8050 0.0100 0.56% 1.7950 1.8350 1.7950
Oct 2, 2024 1.8650 0.0600 3.32% 1.8050 1.8650 1.7850
Oct 1, 2024 1.8550 -0.0300 -1.59% 1.8850 1.9050 1.8250
Sep 30, 2024 1.9150 0.0300 1.59% 1.8850 1.9350 1.8550

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Standard BioTools Inc Company profile

About Fluidigm Corporation

Fluidigm Corporation creates, manufactures, and markets a range of products and services, including instruments, consumables, reagents, and software that are used by researchers and clinical labs. The Company operates in development, manufacturing, and commercialization of tools for life sciences research. Its technology, mass cytometry is a multiplexed solution to analyze cell-surface and intracellular proteins simultaneously in cell suspensions including blood and disassociated tissues. Its Imaging Mass Cytometry (IMC) technology allows multiplexed imaging to understand the composition of tissue microenvironments at a subcellular 1-micron resolution. It markets technologies and life science tools, including preparatory and analytical instruments for mass cytometry, library prep, single cell genomics, and consumables, including integrated fluidic circuits (ifcs), assays, and reagents. Its analytical instruments include Biomark HD System, EP1 System, and Hyperion Tissue Imager.

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, Fluidigm Corporation revenues decreased 5% to $130.6M. Net loss increased 12% to $59.2M. Revenues reflect Development revenue segment decrease of 71% to $2.6M, Instruments segment decrease of 7% to $42.5M, United States segment decrease of 16% to $60.2M, Asia-Pacific segment decrease of 7% to $24M. Higher net loss reflects Research and development increase of 4% to $37.9M (expense), Selling.

Equity composition

Common Stock $0.001 Par, 2/11, 19,938,754 auth, 19,938,754 issd. Insiders own approx. 11.14%.

Industry: Advanced Medical Equipment & Technology (NEC)

2 Tower Place
Suite 2000
SOUTH SAN FRANCISCO
CALIFORNIA 94080
US

News

US elections: Trump leads the polls, but tariff talk spooks investors

As the US elections get closer we look at how Trump’s tariff plans could affect markets.

15:02, 22 October 2024

Gold markets to trade

Last week, we explored the basic fundamental and technical approaches to gold trading. Having covered the key price drivers of this critical asset and how you might use data to trade it, you’re ready to assess the conditions for entry. But there are a range of markets that can effectively give you exposure to gold.

08:00, 21 October 2024

US earnings seasons off to a solid start as focus shifts to tech giants

The US earnings season has started on a positive note, with major banks exceeding expectations and boosting market sentiment.Key themes for the sector include investments in artificial intelligence, capital expenditure returns, and consumer trends in advertising and e-commerce. The S&P 500 continues to climb, driven by strong earnings, resilient economic growth, and the potential for interest rate cuts. Keep an eye on significant support and resistance levels as the market tests new record highs.

14:31, 17 October 2024

ECB Preview: cooling growth and inflation call for another rate cut

Markets are convinced the European Central Bank (ECB) will cut rates by 25 basis points again at Thursday’s meeting.

12:41, 16 October 2024

Australian labour force data forecast to reveal stable jobs market

Australia's labour market remained stable in September 2024, with the unemployment rate forecast to hold at 4.2%, supported by a 25,200 person rise in employment. Despite the economy teetering on the edge of recession, strong hiring trends persist, challenging market economists' predictions.

07:41, 15 October 2024

Applying fundamental and technical strategies to Gold Trading

Last week, we visualised the key potential drivers of gold in a chart focused on recent performance. Understanding the factors that can move gold prices is essential, but translating that knowledge into effective trading strategies is where the real potential can lie.

08:00, 14 October 2024

S&P 500 expected to deliver modest earnings growth in Q3

Earnings growth across the S&P 500 is expected to be modest in Q3, with a projected 4.2% increase in EPS, down from 7.8% in the previous quarter. Information technology, health care, and communication services are poised to drive growth, particularly IT with a forecasted 15% year-over-year EPS increase.

12:40, 11 October 2024

People also watch

Oil - Crude

71.64 Price
+1.870% 1D Chg, %
Long position overnight fee 0.0061%
Short position overnight fee -0.0280%
Overnight fee time 21:00 (UTC)
Spread 0.040

BTC/USD

67,616.45 Price
+0.600% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 106.00

Gold

2,748.27 Price
+0.410% 1D Chg, %
Long position overnight fee -0.0175%
Short position overnight fee 0.0092%
Overnight fee time 21:00 (UTC)
Spread 1.20

US100

20,339.90 Price
+0.490% 1D Chg, %
Long position overnight fee -0.0248%
Short position overnight fee 0.0026%
Overnight fee time 21:00 (UTC)
Spread 7.0

Still looking for a broker you can trust?

Join the 650,000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading